CD38 and neoplasm: This study demonstrates that primary melanoma cells are equipped with both the canonical (CD39/CD73) and the alternative [2, 3] (CD38/CD157/CD203a(PC-1)/CD73) ectoenzymatic pathways for producing ADO at the interface between tumor and host.